proinflammatory
[대역어] 전 염증
[용어속성] Term
[용어속성] Term
Xuanfei Baidu Formula attenuates LPS-induced acute lung injury by inhibiting the NF-κB signaling pathway
Article
[키워드] Activation
acute lung injury
ALI model
alleviate
Analysis
analysis
attenuate
Baidu
caused
Cell
cellular
China
component
Component analysis
components
Compound
COVID-19
COVID-19 patients
demonstrated
experiment
experimental validation
Formula
in vivo
increases in
indicated
Inflammation
ingredient
inhibited
inhibiting
Kyoto
lung
Lung injury
material
mechanism of action
Mild
molecular mechanism
network
network pharmacology
NF-κB pathway
NF-κB signaling
NF-κB signaling pathway
Obstructive
Ontology
p-NF-κB
p65
pathway
pharmacological
predicted
proinflammatory
Proteins
reduced
syndrome
target
treat
Treatment
Xuanfei baidu formula.
[DOI] 10.1016/j.jep.2022.115833 PMC 바로가기
[DOI] 10.1016/j.jep.2022.115833 PMC 바로가기
Potential mechanisms of vaccine-induced thrombosis
Article
[키워드] activate
Ad26.COV2.S
Adenovirus
administration
AdV vector
antibodies
antibody
Autoimmune heparin-induced thrombocytopenia
B cell
Bacteria
BNT162b
cerebral venous sinuse
ChAdOx1
ChAdOx1 nCoV-19
ChAdOx1 nCoV-19 vaccine
characterized
clinical
conformational change
Contact
COVID-19
COVID-19 vaccine
COVID-19 vaccines
described
develop
Effectiveness
elicited
events
expression
Factors
Gene therapy
heparin-induced thrombocytopenia
hexone
immune complex
immune response
Immune thrombocytopenia
immunothrombosis
IMPROVE
induce
intrinsic
knowledge
laboratory feature
mechanism
monocyte
occur
PF4
Platelet
Platelets
Potential
proinflammatory
Protein
receiving
resulting
Spike protein
splice
subject
syndrome
T-cell
thrombosis
Vaccine
Vaccine- induced immune thrombocytopenia and thrombosis.
vectors
Venous thrombosis
viruses
[DOI] 10.1016/j.ejim.2022.08.002 PMC 바로가기
[DOI] 10.1016/j.ejim.2022.08.002 PMC 바로가기
Association of Interleukin-17F Polymorphism and Mortality Predictors with the Risk of COVID-19
Article
[키워드] age
allele
Analysis
association
AUC
case-control study
CD4
cells
Characteristics
control subject
controls
Coronavirus disease-19
COVID-19
COVID-19 infection
COVID-19 mortality
COVID-19 patient
COVID-19 patients
cutoff point
D-dimer
death
determine
enzyme-linked immunosorbent
exhibiting
expression
Genotype
genotyping
healthy
higher odd
hypertension
IL-17
immunological injuries
in-hospital mortality
independent predictor
investigated
Laboratory
no significant difference
non-survivor
outcome
participant
polymorphism
predictor
proinflammatory
risk of COVID-19
ROC Curve
subset
suggested
survivor
susceptibility
T lymphocytes
tested
variant
WBC
White blood cell
with COVID-19
[DOI] 10.1155/2022/4761631 PMC 바로가기
[DOI] 10.1155/2022/4761631 PMC 바로가기
Advances in Biosensing Technologies for Diagnosis of COVID-19
Article
[키워드] advance
Biomarker
biosensor
biosensors.
carrier
Community
contagiousness
COVID-19
COVID-19 biomarkers
COVID-19 diagnosis
COVID-19 pandemic
Diagnosis
diagnosis of COVID-19
Diagnostic biomarkers
diagnostic test
diagnostics
Disadvantages
high mortality
immune response
impacted
Infection
Major
number of sample
pathogenesis of COVID-19
point-of-care
proinflammatory
provide
Research
RT-qPCR
SARS-CoV-2
specimen
Spread
technology
time-consuming
traditional method
viral genomes
Viral proteins
[DOI] 10.3390/bios12100898 PMC 바로가기
[DOI] 10.3390/bios12100898 PMC 바로가기
Palmitoylethanolamide Reduces Proinflammatory Markers in Unvaccinated Adults Recently Diagnosed with COVID-19: A Randomized Controlled Trial
Article
[키워드] adhesion molecules
age
anti-inflammatory effect
Antigen
assigned
baseline
Biomarker
Blood
BMI
C-reactive protein
CDC
chronic condition
coin toss
Concentration
conducted
Controlled
coronavirus disease
covariates
COVID-19
COVID-19 complications
COVID-19, SARS-COV-2
Cytokines
diagnosed with COVID-19
Diagnosis
dietary supplements
double-blind
dysregulated immune response
Effect
exacerbate
ferritin
group
Health
IL-1β
IL-2
IL-6
implicated
indicated
individual
infected with COVID-19
infections
infectious conditions
Inflammation
inflammatory mediator
intercellular
Linear regression model
mechanism
Multiple
outcomes
P-selectin
palmitoylethanolamide
palmitoylethanolamide.
participant
Placebo
placebo tablet
positive test result
Primary outcome
produced
proinflammatory
promote
randomized placebo-controlled trial
Randomly
receive
reduced
reported
RT-PCR
secretion
severity
Sex
significantly
stratified
treatment effect
[DOI] 10.1093/jn/nxac154 PMC 바로가기
[DOI] 10.1093/jn/nxac154 PMC 바로가기
Single-Cell Gene Expression Analysis Revealed Immune Cell Signatures of Delta COVID-19
Article
[키워드] accompanied
accompany
adaptive
B.1.617
Blood
caused
Characteristics
contribute
coronavirus disease
correlated
COVID-19
COVID-19 pathogenesis
Cytokine storm
Delta
delta variant
diagnostic
dominant
Factor
Gene Expression
gene expression signature
high mortality
highlight
immune
immune component
immune response
immune system
Immunity
immunological
individual
Infection
Lineage
lymphoid
molecular
monocyte
Monocytes
mononuclear cell
Multiple
myeloid cells
pathway
performed
proinflammatory
required
Revealed
risk
SARS-CoV-2
SARS-CoV-2 lineage
severity
signature
significant changes in
single-cell
syndrome
targeted therapy
therapeutic
Transcriptome
Transcriptome.
understanding
variant
virus
with COVID-19
[DOI] 10.3390/cells11192950 PMC 바로가기
[DOI] 10.3390/cells11192950 PMC 바로가기
Differential proinflammatory activities of Spike proteins of SARS-CoV-2 variants of concern
Article
[키워드] acute respiratory syndrome
addition
angiotensin-converting enzyme 2
canonical
coronavirus
coronavirus disease
COVID-19
CSS
Cytokine storm syndrome
Genetic
hemorrhages
Host immune response
hyperinflammation
Inflammasome
Inflammation
less
life-threatening
Local
long-lasting
Macrophage
mechanism
neutrophil
pandemic
proinflammatory
proinflammatory activity
promoted
Protein
recruitment
rescued
SARS-CoV-2
SARS-CoV-2 S protein
SARS-CoV-2 variant
spike
systemic hyperinflammation
variant
variants
variants of concern
zebrafish
[DOI] 10.1126/sciadv.abo0732 PMC 바로가기
[DOI] 10.1126/sciadv.abo0732 PMC 바로가기
Targeting Doublecortin-Like Kinase 1 (DCLK1)-Regulated SARS-CoV-2 Pathogenesis in COVID-19
Article
[키워드] Activation
amplified
amplify
analyzed
blocked
Blood
Cell
chemokine
chronic liver disease
Chronic Liver Diseases
circulating
comorbid disease
Comorbidity
contribute
controls
correlated
COVID-19
COVID-19 patients
Critical
cytokine
cytokine secretion
DCLK1
DDCLK1
decrease
disease severity
dysregulation
expression
Factor
Factors
Gain
growth factor
hospitalized patient
Host
Hyperinflammatory response
immune
Immune cell
immune response
immunosuppressive
in viral
in vitro
infected cells
Inflammation
Inflammatory cytokine
inflammatory pathway
inhibition
inhibitor
Innate immunity
involved
kinase
Live virus
liver
livers
loss of function
lung
Lung disease
Macrophage
mononuclear cell
mononuclear cells
Mortality
neutrophil
normalized
Pathogenesis
pathology
Patient
Peripheral blood
potential therapeutic target
Prevalence
pro-inflammatory
profile
proinflammatory
promoted
promoter
Protein
S100A9
SARS-CoV-2
SARS-CoV-2-infected cell
secretion
severity of COVID-19
Signaling
subject
targeting
Treatment
Viremia
virus production
virus replication
Virus replication.
with COVID-19
β-catenin
[DOI] 10.1128/jvi.00967-22 PMC 바로가기
[DOI] 10.1128/jvi.00967-22 PMC 바로가기
PD-1 and ICOS counter-regulate tissue resident regulatory T cell development and IL-10 production during flu
Article
[키워드] accumulated
CD4
Cell
characterized
co-stimulatory receptor
COVID
Critical
Express
expressed
flu
fluorescent
FOXP3
GFP
heterogenous
human population
iCoS
IL-10
Immune homeostasis
immunopathology
in vivo
Infection
infections
Influenza
influenza infection
influenza infections
labeling
lung tissue
memory T cells
molecular feature
PD-1
proinflammatory
promote
Regulatory
Regulatory T cell
repeated
reporter
respiratory infectious disease
response
reveal
secondary infections
shown
Signaling
signaling pathway
suppress
T cell
T cell response
T cells
tissue
tissue repair
tissue resident T cells.
transcription factor
Treg
Treg cell
Treg cells
Tuberculosis
[DOI] 10.3389/fimmu.2022.984476 PMC 바로가기
[DOI] 10.3389/fimmu.2022.984476 PMC 바로가기